Pharmaceutical News

RSS

Researchers develop new, promising class of active ingredients against resistant bacteria

Researchers at the Martin Luther University Halle-Wittenberg have developed a new, promising class of active ingredients against resistant bacteria.

11 Nov 2019

Voters say Congress needs to curb drug prices, but are lawmakers listening?

House Democrats are poised to pass sweeping legislation to lower drug prices using strategies President Donald Trump has endorsed. A Trump aide urged the Republican-controlled Senate to vote on a different package curbing drug prices that was drafted by a senior Republican.

11 Nov 2019

Clinical benefit of anticoagulants for atrial fibrillation decreases with age, shows study

The net clinical benefit of anticoagulants for atrial fibrillation (AF) -- one of the most important causes of irregular heartbeats and a leading cause of stroke -- decreases with age, as the risk of death from other factors diminishes their benefit in older patients, according to a study led by researchers at UC San Francisco.

11 Nov 2019

Opioids do not improve quality of life or depression in OA patients

New research presented at the 2019 ACR/ARP Annual Meeting suggests that opioids contribute no measurable benefit to quality of life or depression for patients with osteoarthritis (OA).

11 Nov 2019

Methotrexate appears to facilitate bone remodeling in patients with osteoarthritis

According to new research findings presented at the 2019 ACR/ARP Annual Meeting, methotrexate did not demonstrate superior efficacy over placebo for pain relief and function evolution at three and 12 months in patients with erosive hand osteoarthritis.

11 Nov 2019

Tocilizumab more effective than rituximab in achieving low disease activity in RA patients

New research discovered that tocilizumab is more effective than rituximab in achieving low disease activity in patients with rheumatoid arthritis whose synovial tissue show a low level of B cell infiltration and did not respond to conventional synthetic disease-modifying anti-rheumatic drugs (conventional synthetic DMARDs) or tumor necrosis factor inhibitors first.

11 Nov 2019

Study provides first data on infectious risk in children exposed to non-TNFi biologics and tofacitinib

A new study found that very few serious infections were seen in children born to mothers with chronic inflammatory diseases who used non-TNFi biologics or tofacitinib during pregnancy compared to children not exposed to these drugs and children exposed to TNFi biologics in utero.

10 Nov 2019

Biologics can be used effectively for both elderly-onset and young-onset RA patients

According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, both patients with rheumatoid arthritis whose disease onset occurred at an older age and those whose disease onset occurred earlier in life have similar improvements in clinical disease at 48 weeks after starting biologic disease-modifying antirheumatic drugs, as well as similar drug maintenance and adverse events discontinuation rates.

10 Nov 2019

Dengue vaccine from Takeda shows promise

Officials have confirmed the initial success with trials of Dengue vaccine. Dengue, a viral disease borne by mosquitoes is considered to be one of the top ten health threats says the world Health Organization (WHO). Since the beginning of the outbreaks and the hundreds of deaths due to this infection, researchers have been on the lookout for vaccines to prevent this infection.

10 Nov 2019

Common muscle relaxant linked to severe confusion in patients with kidney dysfunction

One in 25 patients with very low kidney function were admitted to hospital with severe confusion and other cognitive-related symptoms a few days after being prescribed a common muscle relaxant.

10 Nov 2019

UC researcher finds new treatment option for liver transplant patients

A drug commonly used to treat both asthma and inflammatory bowel disease, budesonide, may also be useful as an anti-organ rejection medication for liver transplant patients leading to fewer serious side effects than the most commonly used therapy, according to a University of Cincinnati researcher.

9 Nov 2019

Kibow Biotech participates in ASN Kidney Week 2019

Kibow Biotech announces its 15th consecutive year of participation in the ASN Conferences after 22 years as a pioneer in the use of Pro/Prebiotics in people with failing kidneys.

From Kibow Biotech Inc. 8 Nov 2019

Promega and Merck collaborate to develop MSI companion diagnostic for use with anti-PD-1 therapy

Promega Corporation today announced it has entered into a global collaboration with Merck, to develop Promega’s microsatellite instability technology.

From Promega Corporation 8 Nov 2019

Three studies present new information on penicillin allergy

At some point you may have had a reaction to penicillin and were told you were allergic. And there's a good chance it has stayed in your chart throughout your childhood and into adulthood.

8 Nov 2019

Allergy shots effective in reducing PFAS symptoms in pediatric patients

We know that children with pollen food allergy syndrome (PFAS) also suffer from seasonal allergies.

8 Nov 2019

Extending Medicare coverage of transplant drugs would benefit patients, reduce healthcare costs

Extending Medicare coverage of transplant medications would benefit patients and reduce healthcare costs.

8 Nov 2019

DuPont to highlight innovative solutions for future pharma challenges at AAPS: PharmSci 360

DuPont Nutrition & Biosciences scientists have proven their expertise through decades of research and manufacturing excellence to create one of the industry’s broadest product portfolios.

From DuPont 8 Nov 2019

New vaccine strategy shows promise against HIV

A collaborative team of scientists has made a successful proof-of-principle demonstration of an advanced HIV vaccine strategy--an approach that may also work in protecting people from an array of other deadly infectious diseases.

7 Nov 2019

Study may help explain effects of cannabidiol on seizure frequency in Lennox-Gastaut patients

Results from a study published in the British Journal of Clinical Pharmacology may help explain why cannabidiol--a chemical component of marijuana with no psychoactive properties--reduces the frequency of seizures in patients with a severe form of epilepsy.

7 Nov 2019

New study reveals why beta-blockers cause skin inflammation

Beta-blockers are often used to treat high blood pressure and other cardiovascular diseases. However, in some patients they can trigger or exacerbate psoriasis, an inflammatory skin disease.

7 Nov 2019

Pharmaceutical News

Researchers develop new, promising class of active ingredients against resistant bacteria

Voters say Congress needs to curb drug prices, but are lawmakers listening?

Clinical benefit of anticoagulants for atrial fibrillation decreases with age, shows study

Opioids do not improve quality of life or depression in OA patients

Methotrexate appears to facilitate bone remodeling in patients with osteoarthritis

Tocilizumab more effective than rituximab in achieving low disease activity in RA patients

Study provides first data on infectious risk in children exposed to non-TNFi biologics and tofacitinib

Biologics can be used effectively for both elderly-onset and young-onset RA patients

Dengue vaccine from Takeda shows promise

Common muscle relaxant linked to severe confusion in patients with kidney dysfunction

UC researcher finds new treatment option for liver transplant patients

Kibow Biotech participates in ASN Kidney Week 2019

Promega and Merck collaborate to develop MSI companion diagnostic for use with anti-PD-1 therapy

Three studies present new information on penicillin allergy

Allergy shots effective in reducing PFAS symptoms in pediatric patients

Extending Medicare coverage of transplant drugs would benefit patients, reduce healthcare costs

DuPont to highlight innovative solutions for future pharma challenges at AAPS: PharmSci 360

New vaccine strategy shows promise against HIV

Study may help explain effects of cannabidiol on seizure frequency in Lennox-Gastaut patients

New study reveals why beta-blockers cause skin inflammation

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Unlocking live single-cell functional insights

Latest News